USP1-IN-3 is a selective USPI inhibitor. USP1-IN-3 inhibits USPI-UAFI with an IC50 value of <30 nM. USP1-IN-3 can be used for the research of cancer.
USP1-IN-3 has inhibitory against USPI-UAFI with an IC50 value of <30 nM[1].USP1-IN-3 has viability for a non-isogenic pair of BRCAI mutant and BRCAI WT cell lines with IC50 values of <100 nM and > 10 μM, respectively[1].
References:
[1]. Scott Throner, et al. Pyrrolo[3,2-d]pyrimidine compounds and methods of use in the treatment of cancer. Patent. WO2022174184A1.
















